Oscar Health, Inc. (OSCR) Stock Price & Analysis
Oscar Health, Inc. (OSCR) closed at USD 33.32 on Thursday, October 22, 2026, down 0.39% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 33.32; the Oct 22, 2026 session ranged USD 32.76–34.1 on volume of 4,363,606 shares. Market capitalization is —, with a 52-week range of USD 10.69–35.01 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:22 UTC.
Also available as compact Markdown for AI agents: nexqual.com/OSCR.md
Key facts (OSCR)
- Last four reported quarters (through Jun 30, 2026): revenue $15.3B, net income $551M (3.6% margin), free cash flow $4.38B (SEC filings).
- 1 of 80 tracked superinvestors hold OSCR (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Total return with dividends: 1Y +69.8% vs S&P 500 +14.9%; 5Y +96.0% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD -0.17, revenue estimate $4.72B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (OSCR)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $1.84B | $3.96B | $5.86B | $9.18B | $11.7B | $15.3B |
| Operating income | -$544M | -$590M | -$236M | $57.3M | -$396M | $630M |
| Net income | -$573M | -$606M | -$271M | $25.4M | -$443M | $551M |
| EPS (diluted) | -$3.20 | -$2.85 | -$1.22 | $0.10 | -$1.69 | — |
| Free cash flow | -$208M | $351M | -$298M | $950M | $1.06B | $4.38B |
| Operating margin | -29.6% | -14.9% | -4.0% | 0.6% | -3.4% | 4.1% |
| Net margin | -31.1% | -15.3% | -4.6% | 0.3% | -3.8% | 3.6% |
| Revenue growth | +297.3% | +115.6% | +47.9% | +56.5% | +27.5% | — |
| Cash + short-term investments | $1.69B | $2.96B | $2.56B | $2.15B | $3.99B | — |
| Total debt | $0K | $298M | $299M | $300M | $430M | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (OSCR)
P/E at fiscal year-ends: Dec 2024 140.5x.
Superinvestors (SEC 13F-HR, Q2 2026) (OSCR)
1 of 80 tracked investors hold OSCR. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Polen Capital | Polen Capital Management | 0.01% | $1.1M | New position |
Analysts (OSCR)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | UBS | Target raised | Neutral | $26 → $36 |
| 2026-09-18 | Raymond James | Target raised | Outperform | $34 → $42 |
| 2026-09-17 | B of A Securities | Target raised | Underperform | $28 → $30 |
| 2026-09-17 | Stephens & Co. | Reiterated | Equal-Weight | $34 |
| 2026-09-17 | Barclays | Target raised | Overweight | $39 → $49 |
| 2026-09-17 | Baird | Target raised | Neutral | $27 → $33 |
| 2026-08-13 | Wells Fargo | Target raised | Equal-Weight | $20 → $27 |
| 2026-08-07 | UBS | Target raised | Neutral | $20 → $26 |
| 2026-08-07 | Barclays | Target raised | Overweight | $35 → $39 |
Total return (dividends reinvested) (OSCR)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +69.8% | +96.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +70.1% | +14.4% |
| Volatility (annualized) | 66.1% | 81.2% |
| Max drawdown | -44.8% (Oct 2025→Mar 2026) | -87.2% (Oct 2021→Dec 2022) |
OSCR suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | Amazon (AMZN) | “We partner with third parties, including Amazon and Google, to support our information technology systems.” |
| Partner | Alphabet (Google) (GOOGL) | “We partner with third parties, including Amazon and Google, to support our information technology systems.” |
Quoted from the company's 10-K filed Feb 13, 2026.
OSCR analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-0.17 | $-0.20 | -15.0% | $4.72B | 7 |
| Next quarter (ends Dec 2026) | $-1.08 | $-1.23 | -11.9% | $4.48B | 7 |
| Current fiscal year (ends Dec 2026) | $1.94 | $1.06 | +82.8% | $18.73B | 8 |
| Next fiscal year (ends Dec 2027) | $2.22 | $1.49 | +49.1% | $20.78B | 8 |
Key Statistics (as of October 23, 2026 at 09:22 UTC)
| Price | USD 33.32 |
|---|---|
| Change | ▼ 0.39% (down) |
| Previous Close | USD 33.32 |
| Open | USD 33.32 |
| Day Range | USD 32.76 – 34.1 |
| 52-Week Range | USD 10.69 – 35.01 |
| Volume | 4,363,606 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (OSCR)
Nexqual's technical model rates OSCR "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 23, 2026 at 09:22 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54.23 (neutral) |
| vs SMA50 | Above (USD 31.82) |
| MACD | 0.58 (positive) |
Earnings (OSCR)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD -0.17 |
| Revenue Estimate | $4.72B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 1.1 vs est 0.38 ▲ beat |
| 2026-03-31 | USD 2.07 vs est 1.1 ▲ beat |
| 2025-12-31 | USD -1.24 vs est -0.92 ▼ miss |
| 2025-09-30 | USD -0.53 vs est -0.58 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:22 UTC.
Financials & Fundamentals (OSCR)
| Total Revenue | $15.32B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +70.40% |
| Gross Margin | +20.16% |
| Operating Margin | +7.96% |
| Profit Margin | +3.60% |
| ROE | +34.26% |
| Debt / Equity | 0.23 |
| Current Ratio | 1.08 |
| Total Cash | $8.56B |
| Total Debt | $482.10M |
Source: Nexqual, October 23, 2026 at 09:22 UTC.
Ownership (OSCR)
| Insider Ownership | +5.16% |
|---|---|
| Institutional Ownership | +74.11% |
| Shares Outstanding | 273.47M |
| Float | 263.61M |
| Short % of Float | +6.51% |
Source: Nexqual, October 23, 2026 at 09:22 UTC.
From Oscar Health, Inc.'s Latest SEC 10-K Filing (filed 2026-02-13)
Key Strengths & Strategy (as disclosed to the SEC)
- As of December 31, 2025, we owned no issued patents or pending patent applications anywhere in the world, and therefore, we do not have patent protection for any of our proprietary technology, which includes our full stack technology platform, proprietary software, mobile application ("app"), or web portal.
- Oscar is a leading healthcare technology company built around a full stack technology platform and a relentless focus on member experience.
- We partner with third parties, including Amazon and Google, to support our information technology systems.
- As an example, we distribute our Amazon Web Services ("AWS") hosted platform across multiple availability zones in an effort to reduce the likelihood of infrastructure failure.
Partnerships
- Disaggregated membership information as of December 31, 2025 and 2024 is presented in the tables below: (1)Represents total membership for our co-branded partnership with Cigna.
Legal & Regulatory Risks (Item 1A, quoted)
- Changes and developments in the health insurance system in the United States and the states in which we operate could also reduce demand for our services and harm our business.
- We are subject to extensive fraud, waste, and abuse laws that may require us to take remedial measures or give rise to lawsuits, audits, investigations and claims against us, the outcome of which may have a material adverse effect on our business, financial condition, cash flows, or results of operations.
- Changes in laws, regulations or rules relating to taxes or tariffs could adversely affect us.
- Changes in laws relating to taxes and tariffs could adversely impact our business, results of operations, financial condition and cash flows.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MOH | Molina Healthcare Inc | USD 216.64 | ▲ 0.81% |
| CNC | Centene Corporation | USD 71.24 | ▲ 1.42% |
| CLOV | Clover Health Investments, Corp | USD 4.73 | ▼ 1.05% |
| PGNY | Progyny, Inc. | USD 29.12 | ▲ 2.39% |
| HUM | Humana Inc. | USD 420.97 | ▼ 1.05% |
| ALHC | Alignment Healthcare, Inc. | USD 8.43 | ▼ 0.12% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:22 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt